Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMRI Appoints CFO | Contract Pharma
Breaking News, Promotions & Moves

AMRI Appoints CFO

Anthony Mattacchione was also appointed senior vice president, and comes with several decades of experience

AMRI has appointed Anthony (‘Tony’) Mattacchione as senior vice president and chief financial officer, effective April 2, 2018. Mr. Mattacchione succeeds Felicia Ladin, who announced her intention to leave AMRI in December 2017.

 

Mr. Mattacchione has more than 30 years of experience in financial leadership positions with high growth companies across the life sciences tools, biopharmaceutical, chemicals and technology sectors. Before joining AMRI, he spent five years at Bruker Corp. where he most recently served as their chief financial officer. 

 

“We are delighted to welcome Tony to AMRI,” said Michael J. Mulhern, chief executive officer, AMRI. “He is a seasoned financial executive with a strong background leading teams in a variety of business environments, including strategic growth and operating model transformations. These attributes, along with his strong personal values and standards, will make him a great addition to our executive team.”

 

“I am excited to join AMRI at this time in the company’s development and growth,” said Mr. Mattacchione. “I look forward to being a strategic and collaborative partner to our executive team and delivering value for AMRI’s global customers, employees and stakeholders as we satisfy critical needs in the market.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters